Advertisement Delcath receives Japanese patent for Delcath system - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Delcath receives Japanese patent for Delcath system

Delcath Systems has been granted a Japanese patent for a modification to its original patented, double-balloon catheter, which allows for the uninterrupted flow of blood to the heart while the patient receives a treatment with the Delcath system.

This patent approval follows Delcath’s recent and successful efforts to extend its patent protection broadly in Europe and Asia. The company has expanded and updated its overseas portfolio to include 20 patents for the Delcath system, in addition to its eight US patents.

The recent Japanese patent secures the same intellectual property protection as Delcath’s rights under the US patent titled Balloon Catheter with Occluded Segment Bypass, and similar patents previously secured in Canada and selected countries in Europe.